Taoka Chemical Co., Ltd.

As of March 31, 2026, Taoka Chemical Co., Ltd. carries a market capitalization of 13.25B, placing it among publicly traded companies globally. Its enterprise value stands at 12.74B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Taoka Chemical Co., Ltd.'s next confirmed earnings release is scheduled for October 29, 2026.

As of March 31, 2026, Taoka Chemical Co., Ltd. has 14.33M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Taoka Chemical Co., Ltd. maintains a current ratio of 2.01, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on October 22, 2026, Taoka Chemical Co., Ltd.'s stock has declined approximately 38.99% over the past 52 weeks. The 50-day moving average sits at 796.16, while the 200-day moving average is 913.40.

As of March 31, 2026, Taoka Chemical Co., Ltd. holds 1.39B in cash and equivalents against 870.00M in total debt, resulting in a net debt position of -517.00M. Total book value stands at 19.55B, with working capital of 8.73B providing operational flexibility.

Taoka Chemical Co., Ltd.'s most recent stock split took place on September 29, 2021 with a 1:5 split ratio.